Capricor Therapeutics Inc. (CAPR) Financial Statements (2024 and earlier)

Company Profile

Business Address 8840 WILSHIRE BLVD
BEVERLY HILLS, CA 90211
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:39,50041,40034,88532,6669,8857,256
Cash and cash equivalents14,6959,60334,88532,6663,8994,259
Short-term investments24,79331,818  5,9862,997
Other undisclosed cash, cash equivalents, and short-term investments12(21)    
Restricted cash and investments      286
Receivables10,372548392 88205
Prepaid expense      
Other undisclosed current assets9839411,1601,011571724
Total current assets:50,85542,88936,43733,67710,5458,471
Noncurrent Assets
Operating lease, right-of-use asset2,0502,3502,822  
Property, plant and equipment5,5614,5881,796851443574
Intangible assets, net (including goodwill)   (260)2650
Intangible assets, net (excluding goodwill)   (260)2650
Other undisclosed noncurrent assets26826853589120152
Total noncurrent assets:7,8797,2064,893942569776
TOTAL ASSETS:58,73450,09541,33034,61911,1149,247
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:6,2234,8353,1162,7258761,149
Other undisclosed accounts payable and accrued liabilities6,2234,8353,1162,7258761,149
Deferred revenue24,27017,981   
Debt    247  
Other liabilities 27     
Due to related parties89    
Other undisclosed current liabilities7496821,017 22106
Total current liabilities:31,27023,5874,1332,9718981,255
Noncurrent Liabilities
Long-term debt and lease obligation3,3763,3762,45371  
Long-term debt, excluding current maturities3,3763,376 71  
Liabilities, other than long-term debt1,48711,346    
Deferred revenue  9,468   
Operating lease, liability1,4871,8782,453  
Other undisclosed noncurrent liabilities   9243,3763,3763,376
Total noncurrent liabilities:4,86314,7225,8293,4483,3763,376
Total liabilities:36,13338,3099,9626,4194,2744,631
Equity
Equity, attributable to parent22,60111,78631,36828,2006,8394,616
Common stock31252421531
Additional paid in capital181,702148,735139,404116,21781,21671,311
Accumulated other comprehensive income (loss)236105  (1)12
Accumulated deficit(159,367)(137,080)(108,060)(88,038)(74,381)(66,739)
Total equity:22,60111,78631,36828,2006,8394,616
TOTAL LIABILITIES AND EQUITY:58,73450,09541,33034,61911,1149,247

Income Statement (P&L) ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues25,1782,5512453101,0051,671
Other income 68191548   
Gross profit:25,1782,5512453101,0051,671
Operating expenses(49,256)(32,249)(21,183)(14,000)(8,739)(16,998)
Operating loss:(24,078)(29,697)(20,938)(13,690)(7,734)(15,327)
Nonoperating income1,7906789163392136
Investment income, nonoperating1,729522573395136
Loss from continuing operations:(22,288)(29,020)(20,023)(13,657)(7,642)(15,191)
Loss before gain (loss) on sale of properties:(20,023)(13,657)(7,642)(15,191)
Net loss available to common stockholders, diluted:(22,288)(29,020)(20,023)(13,657)(7,642)(15,191)

Comprehensive Income ($ in thousands)

3/31/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(22,288)(29,020)(20,023)(13,657)(7,642)(15,191)
Comprehensive loss:(22,288)(29,020)(20,023)(13,657)(7,642)(15,191)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent131105 1(13)1
Comprehensive loss, net of tax, attributable to parent:(22,157)(28,914)(20,023)(13,656)(7,655)(15,190)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: